Insider · CIK 0001653053

Franchi Jean M.

Reports to the SEC for 5 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001653053

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-14	IRONDisc Medicine, Inc.S Sale	Chief Financial Officer	SSale	−6,257 sh	$69.24	−$433K	64,333
2026-04-13	IRONDisc Medicine, Inc.S Sale	Chief Financial Officer	SSale	−400 sh	$69.00	−$27.6K	70,590
2026-02-25	IRONDisc Medicine, Inc.S Sale	Chief Financial Officer	SSale	−353 sh	$69.06	−$24.4K	70,990
2026-02-18	IRONDisc Medicine, Inc.S Sale	Chief Financial Officer	SSale	−3,397 sh	$65.01	−$221K	75,027
2026-02-18	IRONDisc Medicine, Inc.S Sale	Chief Financial Officer	SSale	−3,684 sh	$65.89	−$243K	71,343
2026-02-17	IRONDisc Medicine, Inc.S Sale	Chief Financial Officer	SSale	−4,075 sh	$62.86	−$256K	78,424
2026-02-10	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+25.5K sh	—	—	25,500
2026-02-10	IRONDisc Medicine, Inc.A Award	Chief Financial Officer	AAward	+19K sh	—	—	82,499
2026-01-02	BDSXBIODESIX INC · Stock Options (Right to Buy)A Award	Director	AAward	+6,354 sh	—	—	6,354
2026-01-02	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Director	AAward	+8,164 sh	—	—	8,164
2025-07-17	IRONDisc Medicine, Inc.S Sale	Chief Financial Officer	SSale	−2,031 sh	$59.00	−$120K	63,499
2025-07-10	IRONDisc Medicine, Inc.S Sale	Chief Financial Officer	SSale	−2,000 sh	$57.50	−$115K	65,530
2025-06-16	IRONDisc Medicine, Inc.S Sale	Chief Financial Officer	SSale	−2,000 sh	$52.26	−$105K	67,530
2025-05-20	BDSXBIODESIX INC · Stock Options (Right to Buy)A Award	Director	AAward	+42K sh	—	—	42,010
2025-05-20	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Director	AAward	+92.4K sh	—	—	92,429
2025-04-01	BDSXBIODESIX INCM Exercise/Conversion	Director	MExercise/Conversion	+26.4K sh	—	—	108,140
2025-04-01	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−26.4K sh	—	—	0
2025-02-18	IRONDisc Medicine, Inc.S Sale	Chief Financial Officer	SSale	−3,136 sh	$54.58	−$171K	69,530
2025-02-10	IRONDisc Medicine, Inc.A Award	Chief Financial Officer	AAward	+36K sh	—	—	72,666
2025-02-10	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+36K sh	—	—	36,000
2024-05-21	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Director	AAward	+60.8K sh	—	—	60,766
2024-05-21	BDSXBIODESIX INC · Stock Options (Right to Buy)A Award	Director	AAward	+37.1K sh	—	—	37,050
2024-02-07	IRONDisc Medicine, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+55K sh	—	—	55,000
2024-02-07	IRONDisc Medicine, Inc.A Award	Chief Financial Officer	AAward	+36.7K sh	—	—	36,666
2024-01-01	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Director	AAward	+105K sh	—	—	145,811
2023-08-03	BDSXBIODESIX INCA Award	Director	AAward	+61.7K sh	$1.62	+$100K	81,772
2023-05-23	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Director	AAward	+40.4K sh	—	—	40,422
2023-05-16	REPLReplimune Group, Inc.S Sale	Chief Financial Officer	SSale	−11.4K sh	$18.05	−$205K	128,748
2023-04-01	REPLReplimune Group, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+67.5K sh	—	—	67,500
2023-04-01	REPLReplimune Group, Inc.A Award	Chief Financial Officer	AAward	+45K sh	—	—	140,099
2023-01-03	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Director	AAward	+7,317 sh	—	—	153,150
2023-01-01	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Director	AAward	+62.5K sh	—	—	145,833
2022-05-24	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Director	AAward	+83.3K sh	—	—	83,333
2022-05-16	REPLReplimune Group, Inc.S Sale	Chief Financial Officer	SSale	−3,436 sh	$14.59	−$50.1K	95,099
2022-04-01	REPLReplimune Group, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+78.8K sh	—	—	78,750
2022-04-01	REPLReplimune Group, Inc.A Award	Chief Financial Officer	AAward	+52.5K sh	—	—	98,535
2022-03-31	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2022-03-31	BDSXBIODESIX INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	—	—	20,044
2021-06-29	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Director	AAward	+20K sh	—	—	20,044
2021-04-01	REPLReplimune Group, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+69.1K sh	—	—	69,050
2021-04-01	REPLReplimune Group, Inc.A Award	Chief Financial Officer	AAward	+46K sh	—	—	46,035
2021-01-14	REPLReplimune Group, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+14.9K sh	$14.08	+$210K	14,900
2021-01-14	REPLReplimune Group, Inc.S Sale	Chief Financial Officer	SSale	−14.3K sh	$44.55	−$637K	600
2021-01-14	REPLReplimune Group, Inc.S Sale	Chief Financial Officer	SSale	−600 sh	$44.00	−$26.4K	0
2021-01-14	REPLReplimune Group, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−14.9K sh	—	—	140,000
2021-01-13	REPLReplimune Group, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+100 sh	$14.08	+$1,408	100
2021-01-13	REPLReplimune Group, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−100 sh	—	—	154,900
2021-01-13	REPLReplimune Group, Inc.S Sale	Chief Financial Officer	SSale	−100 sh	$44.19	−$4,419	0
2020-12-14	REPLReplimune Group, Inc.S Sale	Chief Financial Officer	SSale	−17.9K sh	$43.70	−$780K	7,144
2020-12-14	REPLReplimune Group, Inc.S Sale	Chief Financial Officer	SSale	−389 sh	$42.09	−$16.4K	0

Recent filings

Accepted (ET)
Apr 154
Franchi Jean M.0001193125-26-157187
SEC(opens sec.gov)
Feb 274
Franchi Jean M.0001193125-26-083027
SEC(opens sec.gov)
Feb 194
Franchi Jean M.0001193125-26-059760
SEC(opens sec.gov)
Feb 114
Franchi Jean M.0001193125-26-047163
SEC(opens sec.gov)
Jan 64
Franchi Jean M.0000905148-26-000074
SEC(opens sec.gov)
Jul 184
Franchi Jean M.0000950170-25-096967
SEC(opens sec.gov)
Jul 144
Franchi Jean M.0000950170-25-095684
SEC(opens sec.gov)
Jun 184
Franchi Jean M.0000950170-25-087963
SEC(opens sec.gov)
May 224
Franchi Jean M.0000905148-25-001892
SEC(opens sec.gov)
Apr 24
Franchi Jean M.0000905148-25-001049
SEC(opens sec.gov)
Feb 204
Franchi Jean M.0000950170-25-024472
SEC(opens sec.gov)
Feb 124
Franchi Jean M.0000950170-25-019092
SEC(opens sec.gov)

Companies

Address

C/O DISC MEDICINE, INC. 321 ARSENAL STREET, SUITE 101

WATERTOWN, MA, 02472